POLA PENGGUNAAN OBAT-OBATAN PADA PASIEN SIROSIS HATI RAWAT INAP RSUD PANYABUNGAN

Abstrak

Liver cirrhosis is a diffuse chronic liver disease which is the final stage of chronic liver disease. Proper treatment of cirrhosis patients is needed to ensure the quality of life of patients. This study aims to determine the type of drugs given and to determine the accuracy of drug use in patients with hepatic cirrhosis inpatient care at RSUD PANYABUNGAN. This research is non-experimental research using an observational method with a descriptive cross-sectional research design. Data collection is conducted retrospectively based on the patients medical record from January to December 2017. The sample used in this study was 36 patients who met the inclusion criteria. The results showed the drugs used in patients with liver cirrhosis were diuretic drugs 20.16%, hepatoprotector 13.02%, antibiotics 12.18% multivitamins and minerals 9.24%, beta blockers 4.20%, antiamuba 1.68%, antiviral 1.68%, and kolagogum 0,84%.